Real-time enrollment status for this neurofibromatosis type 2 clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:39 AM UTC
| NCT Number | NCT04374305 |
| Recruiting Status | Recruiting |
| Condition | Neurofibromatosis Type 2 |
| Phase | Clinical Trial |
| Target Enrollment | 109 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Scott R. Plotkin, MD, PhD |
| Last Updated on CT.gov | May 6, 2026 (May 6, 2026) |
As of July 13, 2026: Clinical trial NCT04374305 is currently recruiting participants. This clinical trial study for neurofibromatosis type 2 is actively seeking new participants at 6 locations across the United States. The study is sponsored by Scott R. Plotkin, MD, PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04374305 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04374305 was last updated May 6, 2026 (May 6, 2026). HelloStudys verifies this status automatically.